Carcinoma, Hepatocellular
-
Subject Areas on Research
-
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.
-
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.
-
2017 Version of LI-RADS for CT and MR Imaging: An Update.
-
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
-
5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.
-
A Model for Adaptive Decision Making of "Ablate-and-Wait" Versus Transplantation in Patients With Hepatocellular Carcinoma.
-
A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine.
-
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.
-
A farewell to Barcelona Clinic Liver Cancer (BCLC) classification for hepatocellular carcinoma.
-
A long-term experience with expansion of Milan criteria for liver transplant recipients.
-
A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.
-
A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.
-
A pathological fracture and a solitary mass in the right clavicle: an unusual first presentation of HCC and the role of immunohistochemistry.
-
A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver.
-
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.
-
A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma.
-
A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
-
A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element.
-
ACR Appropriateness Criteria® Chronic Liver Disease.
-
ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update.
-
AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
-
ALPPS Procedure for Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Revealing a Terra Incognita.
-
Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
-
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
-
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.
-
Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis.
-
Acting in the face of uncertainty.
-
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.
-
Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
-
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
-
An update for LI-RADS: Version 2018. Why so soon after version 2017?
-
Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma.
-
Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis.
-
Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells.
-
Apoptosis and cytokines in non-alcoholic steatohepatitis.
-
Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
-
Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
-
Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers.
-
Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.
-
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.
-
Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma.
-
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.
-
Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells.
-
BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis.
-
Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
-
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
-
Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list.
-
Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol.
-
Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
-
CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
-
CD24 as a Novel Predictive Biomarker in Patients with Hepatocellular Carcinoma: Friend or Foe?
-
CHML promotes liver cancer metastasis by facilitating Rab14 recycle.
-
CT arterial portography: causes of technical failure and variable liver enhancement.
-
CT during arterial portography: diagnostic pitfalls.
-
CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
-
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
-
Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings?
-
Case 23-2005: a man with a mass in the liver.
-
Cases from the Osler Medical Service at Johns Hopkins University.
-
Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology.
-
Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.
-
Challenges in screening for hepatocellular carcinoma in the glycogen storage disease type 1a population.
-
Challenging choices: liver transplantation for hepatocellular carcinoma.
-
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.
-
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
-
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.
-
Cirrhosis of the liver in long-term marrow transplant survivors.
-
Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.
-
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.
-
Clinical impact of an adaptive statistical iterative reconstruction algorithm for detection of hypervascular liver tumours using a low tube voltage, high tube current MDCT technique.
-
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
-
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
-
Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.
-
Combined hepatocellular and cystadenocarcinoma presenting as a giant cyst of the liver--a case report.
-
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
-
Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas.
-
Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
-
Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene.
-
Computed tomography of primary liver tumors in children.
-
Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
-
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.
-
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
-
Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis.
-
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
-
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
-
Data-Driven Modification of the LI-RADS Major Feature System on Gadoxetate Disodium-Enhanced MRI: Toward Better Sensitivity and Simplicity.
-
Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma.
-
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
-
Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.
-
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy.
-
Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT.
-
Detection of liver masses with spiral computed tomography.
-
Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
-
Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.
-
Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
-
Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in medaka (Oryzias latipes): consensus of a National Toxicology Program Pathology Working Group.
-
Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.
-
Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT.
-
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.
-
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
-
Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta.
-
Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
-
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
-
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.
-
Discovery of Druggable Host Factors Critical to Plasmodium Liver-Stage Infection.
-
Discussion.
-
Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
-
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
-
Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy.
-
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
-
Dual-Energy Multidetector Computed Tomography With Iodine Quantification in the Evaluation of Portal Vein Thrombosis: Is It Possible to Discard the Unenhanced Phase?
-
Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer.
-
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis.
-
E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma.
-
EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
-
Editorial: frequency of surveillance and survival in hepatocellular carcinoma-authors' reply.
-
Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
-
Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study.
-
Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. I. Effect of amino acid supply.
-
Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. II. Effect of serum and insulin.
-
Effect of growth conditions on the ornithine decarboxylase activity of rat hepatoma cells.
-
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.
-
Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
-
Effectiveness of Transarterial Embolization of Hepatocellular Carcinoma as a Bridge to Transplantation.
-
Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation.
-
Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial.
-
Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.
-
Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma.
-
Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
-
Epithelial-mesenchymal transitions and hepatocarcinogenesis.
-
Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression.
-
Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.
-
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
-
Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
-
Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study.
-
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline.
-
Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?
-
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
-
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.
-
Focal fatty infiltration: a cause of nontumorous defects in the left hepatic lobe during CT arterial portography.
-
Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?
-
Four-dimensional magnetic resonance imaging using axial body area as respiratory surrogate: initial patient results.
-
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
-
Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era.
-
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
-
Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
-
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
-
Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.
-
Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
-
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
-
Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.
-
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.
-
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.
-
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.
-
Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.
-
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
-
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
-
Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.
-
Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.
-
Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma.
-
Hepatic adenoma and focal nodular hyperplasia.
-
Hepatic adenoma: MR appearance mimicking focal nodular hyperplasia.
-
Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma.
-
Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment?
-
Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
-
Hepatitis C.
-
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
-
Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
-
Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progression.
-
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.
-
Hepatocellular Carcinoma Surveillance.
-
Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.
-
Hepatocellular adenoma among adult survivors of childhood and young adult cancer.
-
Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.
-
Hepatocellular carcinoma and model for end-stage liver disease exceptions: the more we understand, the more challenging the allocation gets.
-
Hepatocellular carcinoma arising from ectopic liver tissue in the pancreas.
-
Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.
-
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.
-
Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?
-
Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout.
-
Hepatocellular carcinoma in glycogen storage disease type Ia: a case series.
-
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
-
Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
-
Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
-
Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up.
-
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
-
Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
-
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature.
-
Hepatocellular carcinoma.
-
Hepatocellular carcinoma: clinical and angiographic findings and predictability for surgical resection.
-
Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.
-
Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective.
-
How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
-
How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma.
-
Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers.
-
Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.
-
Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
-
Hypoxia inhibits induction of aryl hydrocarbon receptor activity in topminnow hepatocarcinoma cells in an ARNT-dependent manner.
-
I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.
-
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
-
Ignore reality but not the consequences of its ignorance: Broaden guidelines in surgery of hepatocellular carcinoma.
-
Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device--initial observations.
-
Imaging in Patients with Cirrhosis: Current Evidence.
-
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
-
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
-
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
-
Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
-
Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis.
-
Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma.
-
Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein.
-
Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma.
-
Improved survival and higher rates of surgical resection associated with hepatocellular carcinoma in children as compared to young adults.
-
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.
-
In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography.
-
In vivo visualization of abdominal malignancies with acoustic radiation force elastography.
-
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors.
-
Increased expression of estrogen receptor beta in pachytene spermatocytes after short-term methoxyacetic acid administration.
-
Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
-
Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.
-
Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients.
-
Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells.
-
Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
-
Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.
-
Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
-
Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC.
-
Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
-
Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma.
-
Invited Commentary: Key Role of Imaging in Management and Prognosis of Hepatocellular Carcinoma.
-
Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.
-
Is diaphragm motion a good surrogate for liver tumor motion?
-
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
-
LI-RADS 2017: An update.
-
LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
-
LI-RADS ancillary feature prediction of longitudinal category changes in LR-3 observations: an exploratory study.
-
LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
-
LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data.
-
LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.
-
LI-RADS: a glimpse into the future.
-
LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.
-
Laparoscopic Hepatectomy for Hepatocellular Carcinoma: The Opportunities, the Challenges, and the Limitations.
-
Laparoscopic staging for hepatobiliary carcinoma.
-
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role.
-
Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
-
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
-
Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma.
-
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
-
Liver and intestine transplantation in the United States 1998-2007.
-
Liver and intestine transplantation in the United States, 1997-2006.
-
Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway.
-
Liver imaging: it is time to adopt standardized terminology.
-
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.
-
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
-
Liver transplantation for glycogen storage disease type Ia.
-
Liver transplantation for hepatocellular carcinoma: Management after the transplant.
-
Liver transplantation for liver malignancies in Wilson's disease: two novel cases.
-
Liver transplantation for the treatment of hepatocellular carcinoma.
-
Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.
-
Living donor liver transplantation.
-
Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.
-
Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
-
Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
-
Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
-
Long-term outcomes following microwave ablation for liver malignancies.
-
Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
-
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
-
Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression.
-
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.
-
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
-
Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
-
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.
-
MR-PET co-registration in upper abdominal imaging: quantitative comparison of two different T1-weighted gradient echo sequences: initial observations.
-
MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.
-
MRI-based treatment planning for liver stereotactic body radiotherapy: validation of a deep learning-based synthetic CT generation method.
-
MRI-based treatment planning for proton radiotherapy: dosimetric validation of a deep learning-based liver synthetic CT generation method.
-
Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance.
-
Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
-
Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations.
-
Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review.
-
Mechanisms of disease progression in nonalcoholic fatty liver disease.
-
Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
-
MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B.
-
MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma.
-
Minimal Risk of Biliary Tract Complications, Including Hepatic Abscess, After Transarterial Embolization for Hepatocellular Carcinoma Using Concentrated Antibiotics Mixed with Particles.
-
Mitochondrial transcription factor A induction by redox activation of nuclear respiratory factor 1.
-
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.
-
Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: A Secondary Analysis of a Prospective Observational Study.
-
Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.
-
Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma.
-
Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose?
-
Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells.
-
Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.
-
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
-
NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.
-
Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells.
-
Nodular regenerative hyperplasia in partial hepatectomy specimens.
-
Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes.
-
Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?
-
Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
-
Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
-
Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.
-
Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study.
-
Novikoff hepatoma deoxyribonucleic acid polymerase. Sensitivity of the beta-polymerase to sulfhydryl blocking agents.
-
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.
-
On confirmation bias in imaging research.
-
Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.
-
Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
-
Opportunities for targeted therapies in hepatocellular carcinoma.
-
Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation.
-
Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis.
-
Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.
-
Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma.
-
Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model.
-
Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells.
-
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium.
-
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
-
Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma.
-
Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
-
Overcoming Treatment Disparities for Early-Stage Hepatocellular Carcinoma in the Veteran Population: Is the MISSION Act the Solution?
-
Overexpression of caspase-3 in hepatocellular carcinomas.
-
Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
-
Oxygen flux analysis to understand the biological function of sirtuins.
-
PGC-1beta in the regulation of hepatic glucose and energy metabolism.
-
Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma.
-
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium.
-
Pathology and imaging of hepatocellular neoplasms: are findings from Asian populations applicable to non-Asian groups?
-
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
-
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
-
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.
-
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers.
-
Physician-assisted suicide and advance directives concerning life support.
-
Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
-
Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
-
Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.
-
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.
-
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.
-
Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
-
Predicting recurrence patterns after resection of hepatocellular cancer.
-
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.
-
Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
-
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.
-
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
-
Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma.
-
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis.
-
Primary hepatic neoplasms arising in cirrhotic livers can have a variable spectrum of neuroendocrine differentiation.
-
Problems for risk assessment of endocrine-active estrogenic compounds.
-
Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System.
-
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.
-
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
-
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
-
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.
-
Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma.
-
Progression of Treated versus Untreated Liver Imaging Reporting and Data System Category 4 Masses after Transcatheter Arterial Embolization Therapy.
-
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
-
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
-
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.
-
Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
-
RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
-
Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description.
-
Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
-
Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.
-
Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers.
-
Radiofrequency ablation of liver tumors: influence of technique and tumor size.
-
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
-
Rapid degradation of puromycyl peptides in hepatoma cells and reticulocytes.
-
Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center.
-
Reassessing hepatocellular carcinoma staging in a changing patient population.
-
Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
-
Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.
-
Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.
-
Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
-
Ring finger protein 121 is a potent regulator of adeno-associated viral genome transcription.
-
Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
-
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
-
Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis.
-
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.
-
Role of computed tomography in screening for hepatocellular carcinoma in patients with cirrhosis.
-
Role of exosomes in treatment of hepatocellular carcinoma.
-
Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria.
-
Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma.
-
Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma.
-
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
-
Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma.
-
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
-
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model.
-
Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry.
-
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial.
-
Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis.
-
Stemming the tide of hepatitis B virus related hepatocellular carcinoma?
-
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
-
Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report.
-
Structural characterization of the 5' regions of the human phenylalanine hydroxylase gene.
-
Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.
-
Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging.
-
Surgical clearance for the patient with chronic liver disease.
-
Surgical resection for benign and malignant liver disease.
-
Surgical resection for small hepatocellular carcinoma.
-
Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
-
Surveillance for hepatocellular carcinoma.
-
Sustained expression of human factor VIII in mice using a parvovirus-based vector.
-
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.
-
Targeting Histone Deacetylase 6 Reprograms Interleukin-17-Producing Helper T Cell Pathogenicity and Facilitates Immunotherapies for Hepatocellular Carcinoma.
-
Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
-
Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.
-
Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies.
-
Technical modifications and outcomes after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for primary liver malignancies: A systematic review.
-
Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis.
-
Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial.
-
The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
-
The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis.
-
The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial.
-
The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.
-
The Prognosis of Hepatocellular Carcinoma Treated with Sorafenib in Combination with TACE.
-
The Role of Angiogenesis in Hepatocellular Carcinoma.
-
The Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis.
-
The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.
-
The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma.
-
The effect of protein nutrition on host and tumor metabolism.
-
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
-
The effects of hepatic cryosurgery on tumor growth in the liver.
-
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
-
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
-
The induction of ornithine decarboxylase in cultured hepatoma cells.
-
The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
-
The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.
-
The natural history of hepatitis C viral infection.
-
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
-
The role of external beam radiotherapy in the treatment of hepatocellular cancer.
-
The struggle for intensive care coverage of patients with hepatobiliary malignancies in Greece: Patients are not numbers.
-
The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells.
-
The unique identity of rat hepatoma phenylalanine hydroxylase.
-
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention.
-
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention.
-
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
-
Tissue- and development-specific expression of the human phenylalanine hydroxylase/chloramphenicol acetyltransferase fusion gene in transgenic mice.
-
Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
-
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
-
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.
-
Travel distance and overall survival in hepatocellular cancer care.
-
Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?
-
Trends in the Mortality of Hepatocellular Carcinoma in the United States.
-
Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.
-
U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
-
Understanding Factors Governing Distribution Volume of Ethyl Cellulose-Ethanol to Optimize Ablative Therapy in the Liver.
-
Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical Practice.
-
Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
-
Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.
-
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
-
User and system pitfalls in liver imaging with LI-RADS.
-
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.
-
Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
-
V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.
-
Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice.
-
Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.
-
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
-
Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
-
Vitamins E and K induce aryl hydrocarbon hydroxylase activity in human cell cultures.
-
White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
-
Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.
-
Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
-
Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1.
-
Worse outcome of sorafenib therapy associated with ascites and Child-Pugh score in advanced hepatocellular carcinoma.
-
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.
-
p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.
-
Keywords of People
-
Choi, Steven Sok,
Associate Professor of Medicine,
Medicine, Gastroenterology
-
McDonnell, Donald Patrick,
Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology, in the School of Medicine,
Cell Biology
-
Stinnett, Sandra Sue,
Associate Professor of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics